Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s proprietary technology platforms specialize in ODT, taste masking and customized drug release. To learn more, please visit us at www.AdarePharma.com
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
BASF offers comprehensive solutions to the pharmaceutical industry, ranging from a broad, high-quality excipients portfolio to chemical raw materials. With its expertise in polymer chemistry, its worldwide R&D-capabilities and the company’s commitment to developing value-adding excipients, BASF continuously creates solutions to challenges related to Instant-and-Modified-Release, Solubilization, Softgels, Skin-Delivery and Biologics
Gattefossé provides excipients and drug delivery solutions to healthcare industries worldwide. Committed to advances in drug delivery and innovation, we stay current with the emerging needs and remain steadfast in sharing with customers our knowledge through a well-established network of services and technical support personnel in over 70 countries.
Halozyme's proprietary ENHANZE® drug delivery technology is based on its patented recombinant human hyaluronidase enzyme (rHuPH20). Using rHuPH20 enables some biologics to be delivered rapidly in large volumes subcutaneously, which can potentially improve efficiencies for healthcare systems, reduce overall administration time and may reduce the treatment burden for patients.
Recro Gainesville is the oral solid dose expert specializing in modified release technology, phase-appropriate formulation and analytical development, regulatory support, DEA controlled substances, and high potency compounds. Recro has the experts to deliver clients’ most complex pharmaceutical development and manufacturing projects in its best-in-class, 120,000 square feet of manufacturing space. For more information about Recro’s flexible CDMO solutions, visit www.recrogainesville.com.
At every stage—disease research, drug discovery/development, quality control, manufacturing—you need the right answers. All pharmaceuticals must undergo rigorous testing to ensure they are safe and effective. Agilent understands your workflows and has a comprehensive portfolio of sample-to-data solutions that work seamlessly together, providing accurate and reproducible results.
As a global leader in providing cellulose derivatives to the pharmaceutical industry, Ashland helps take the guesswork out of controlled release solutions. Our extensive product lines offer various degrees of both hydrophilicity and molecular weights, providing formulators with a host of options. The combination of our comprehensive product line, along with our passion and dedication to deliver solutions, results in the option to offer tailored release profiles that are designed to meet the needs of our customers’ drug molecules.
CureVac is a leading biotechnology company in the field of messenger RNA (mRNA) technology with expertise in developing and optimizing this versatile molecule for medical purposes. The principle of CureVac's technology is using mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting different diseases.
DigiM is the leader in characterizing pharmaceutical products with 3D micro-imaging analytics. We provide a one-stop image-based solution to help advance development of CR products, solid dosage forms, and delivery systems. Our quantitative analysis includes microstructure properties such as microporosity, dissolution, and diffusion.
VCM (Vacuum-Compression-Molding) is a lossless screening approach dedicated to controlled release studies, ASDs, HME and lossless formulation screening. The Technology transforms thermoplastic materials in homogeneous specimens without altering the source materials’ characteristics. This novel method is designed as a fast, straight-forward and lossless process to meet demanding pharmaceutical requirements.
Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary microneedle patch technology that increases patient access to therapies by simplifying and improving the way actives are administered, stored, and distributed.
MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. We offer pharmaceutical raw materials for formulation, a wide range of APIs and drug delivery compounds, including PEGs, lipids and PEG lipids. Our Emprove® Program provides extensive regulatory documentation to facilitate risk assessment and qualification processes.
We are Sanofi, a global biopharmaceutical company committed to healthcare solutions from prevention to treatment. We turn scientific discoveries into medicine to improve human health. Every day we dedicate our most importatnt resource, our people, to support patients and families through their health journey.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes veterinary vaccines, medicines and diagnostics, which are complemented by genetic tests, biodevices and a range of services.“